Back
Speaker illustration

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)

Member of:

European Society of Cardiology

Dr. Darren K. McGuire, M.D is a general cardiologist in the Division of Cardiology at the University of Texas Southwestern Medical Center, and a clinical trialist with expertise in large-scale CV outcomes trial design and execution, and drug registration/regulation, with a focus on diabetes and cardiovascular disease. He is a Distinguished Teaching Professor of Medicine with Tenure, is the Jere H. Mitchell, M.D. Distinguished Chair in Cardiovascular Science and is the Lead Physician of the Parkland Health and Hospital System Cardiology Clinics. Dr. McGuire participated in numerous international cardiovascular clinical outcomes trials, including T2DM, obesity, and lipid trials. Dr. McGuire is a previous member of the FDA Cardiovascular and Renal Drugs Advisory Committee. He is Deputy Editor of Circulation, Senior Editor of Diabetes and Vascular Disease Research, and co-editor of the textbook: Diabetes in Cardiovascular Disease: A Companion to Braunwald’s Heart Disease.

Sessions Presentations Articles

A cross-specialty focus – Who are the appropriate patients for SGLT2is?

Event: ESC Congress 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium - Experts on the Spot

Access
Thumbnail

Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?

Event: ESC Congress 2019

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Access
Thumbnail

Five things cardiologists should know about diabetes

Event: ESC Congress 2018

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Access
Thumbnail

Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session type: Satellite Symposium

Access
Thumbnail

Improving cardiovascular outcomes in patients with type 2 diabetes: our clinical experience with empagliflozin

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session type: Satellite Symposium - Experts on the Spot

Access
Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb